Moreover, as more knowledge is now available about the implication of IL-17, IL-19, IL-33, and TSLP in AD pathogenesis, directed therapies against these cytokines and factors were also developed and emerge as interesting alternatives for patients, even if more research still needs to be completed in this area [75]. The gene discussed is TSLP; the disease is Alzheimer disease.